Although Brandt and Lessell' reviewed migrainous phenomena in systemic lupus erythematosus (SLE), the prevalence of migrainous and other headaches in this disorder appears to have received scant attention. Atkinson and Appenzeller2 in a retrospective review studied the notes of 61 patients with SLE and found no difference in the incidence of headache between those patients with and without central nervous systemic lupus.
It was the clinical impression of one of us (MLS) that migrainous headaches were more common in patients with SLE. In order to test the hypothesis a detailed questionnaire was constructed and given to 30 lupus patients and 30 controls.
Materials and methods
The questionnaire established the age of onset of SLE (which was defined as when the patient was informed of the diagnosis) and inquired into any history of previous or current, classical or common migraine. Classical migraine was considered to be present when a frequently unilateral throbbing headache, usually associated with nausea, vomiting, and photophobia, was preceded or accompanied by an aura which could be visual, motor, or sensory. A family history of migraine was sought and whether the patient's migraine (classical or common) had become worse since the diagnosis of SLE or had increased with a flare of SLE activity. Questions were also asked about the previous or current use of oral contraception and whether Raynaud's phenomenon was present and if so whether its severity was related to the frequency and severity of migraine headaches. A history of any previous or current drug therapy was taken.
It was calculated that on the basis of an expected difference of 25% in the prevalence of migraine in SLE and controls a total sample of 60 subjects would be required in order to give an 80% chance of detecting the difference in prevalence at the 5 One of the authors (DM) was present while the questionnaire was being completed to help clarify problems with interpretation of any of the questions.
Results
Classical migraine was found to be significantly more prevalent in the lupus group p=0°05 (Table 1) . Common migraine was less frequent in the SLE group than in the controls, though not to a statistically significant degree. In addition 3 of the SLE patients described visual manifestations suggestive of a migrainous phenomenon (flashing lights in one half of the visual field) but no accompanying headache. No similar episodes were recorded in the control group. The age of onset of classical migraine in the SLE patients ranged from 8 to 44 years (mean 26 7 years, SD 13 -1 years), while in the control group the range was 12 to 21 (mean 16 6 years, SD 3-2 years). The difference in the means was not statistically significant. Further details of the age of onset of migraine in the 2 groups are shown in Table 2 .
No significant difference in the existence of a family history of migraine was evident in the 2 groups (Table 3) . It was not possible to distinguish accurately in retrospect the different types of migraine in the family and they were therefore considered collectively. None of the lupus patients or those in the control group with any sort of migrainous phenomena were currently on the contraceptive pill. Onset over 5 years before diagnosis of SLE 4 5 Onset 1-5 years after diagnosis of SLE 3 5 Onset over 5 years after diagnosis of SLE 2 2 The figures in brackets refer to all types of migraine.
Eight patients in each group with migrainous phenomena had previously used oral contraception. Out of the 7 lupus patients whose classical migraine antedated the diagnosis of SLE 3 subsequently noted an increase in symptoms with the onset of the disease. In 2 patients no change occurred after the onset of SLE, while 2 patients noted an improvement in their symptoms. Only 2 out of the 12 patients with classical migraine in SLE noted any increases in symptoms in association with flare of disease activity. One of the 2 patients with common migraine and SLE but none ofthe 3 with simple visual disturbance noted any increase in symptoms.
An attempt was made to correlate the frequency of migraine headaches with Raynaud's phenomenon (Table 4) . Patients with SLE and Raynaud's phenomenon were no more likely to experience classical or common migraine than patients with SLE without Raynaud's.
Discussion
A recent list of the neurological manifestations of SLE4 fails to mention migraine. However, both Friedman5 and Hughes6 have claimed that migraine occurs frequently in SLE. The relatively high prevalence of migraine in a normal population suggested the need for a controlled study in patients with SLE to determine the significance of these previous observations. The prevalence of migraine in the general population has been reported as high as 29 %7 in females, though Brandt and Lessell in an uncontrolled study found a prevalence of 5 % in 1 100 patients seen in a rheumatology clinic. In the present study 30% of our control group had some form of migraine (15 % classical and 15% common migraine). Waters has discussed8 the possible reasons for the variation in the reported prevalence of migraine.
The prevalence of classical migraine in this study was significantly increased in the lupus group. There appeared to be no association between the frequency and severity of classical or common migraine with disease activity. Brandt and Lessell' reported that in their patients migrainous symptoms were commonly associated with exacerbations of SLE and in some cases responded to corticosteroid therapy. A controlled prospective study would be required to confirm these observations. Raynaud's phenomenon is common in SLE3 ( Table 4 ). The severity of Raynaud's phenomenon did not correlate with the frequency and severity of classical or common migraine. It was considered that small-vessel disease might underlie the clinical phenomena of SLE, including Raynaud's disease, and contribute to the cerebrovascular mechanism causing migraine.9 Despite the lack of correlation between exacerbation of lupus and Raynaud's phenomenon in the present study it seems reasonable to suggest that any young female patient with migraine and Raynaud's phenomenon should be further investigated to exclude SLE.
Oral contraception was not associated with an increased prevalence of migraine in the SLE patients compared with controls. There was no difference in the frequency of a positive family history of migraine between the patients and controls. These observations would support the clinical impression that there is an increased prevalence of migraine in SLE and that it may be part of the disease process. However, unlike Brandt and Lessell' we did not exclude from the present study patients with a family history of migraine or a history of migraine commencing during or before adolescence. It 
